buthionine sulfoximine has been researched along with Endometrial Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etzl, R; Faigle, G; Heublein, S; Jeschke, U; Kuhn, C; Makrigiannakis, A; Navrozoglou, I; Rotzoll, D; Stefos, T; Vrekoussis, T | 1 |
1 other study(ies) available for buthionine sulfoximine and Endometrial Neoplasms
| Article | Year |
|---|---|
Alpha tocopherol transfer protein (αTTP) is expressed in endometrial carcinoma and is correlated with FIGO stage and 5-year survival.
Topics: Amidines; Buthionine Sulfoximine; Carrier Proteins; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Neoplasm Staging; Oxidative Stress; Prognosis; Up-Regulation | 2017 |